2 unchanged sentences
On May 2, 2019, we announced that our Board of Directors approved a $50.0 million share repurchase program with $30.0 million to be utilized for an accelerated share repurchase program, which was completed in January 2020, and $20.0 million reserved for open market repurchases which represents the maximum value of shares that may yet be purchased.
−Removed: No open market repurchases were made during the six-month period ended June 30, 2022.
+Added: No open market repurchases were made during the nine-month period ended September 30, 2022.
Exhibit  
+Added: Certificate of Incorporation of Anika Therapeutics, Inc.
+Added: (incorporated by reference to Exhibit 3.1 to the Current Report on Form 10-K (File No.
+Added: 001-14027) filed by the Registrant on March 11, 2022)
+Added: Bylaws of Anika Therapeutics, Inc., effective as of June 6, 2018 (incorporated by reference to Exhibit 3.2 to the Current Report on Form 10-K (File No.
+Added: 001-14027) filed by the Registrant on March 11, 2022)
Anika Therapeutics, Inc.
−Removed: 2017 Omnibus Incentive Plan (as amended effective June 8, 2022) (incorporated by reference to Exhibit 99.1 to the Current Report on Form 8-K filed on June 10, 2022)
+Added: 2017 Omnibus Incentive Plan (as amended effective June 8, 2022) (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed (File No.
+Added: 000-21326) by the Registrant on June 10, 2022)
Rule 13a-14(a)/15d-14(a) Certifications
Certification of Dr.
−Removed: Blanchard, pursuant to Rules  
−Removed: 13a-15(e)  
−Removed: and 15d-15(e), as adopted pursuant to Section  
−Removed: 302 of the Sarbanes-Oxley Act of 2002.
−Removed: Certification of Michael Levitz, pursuant to Rules  
−Removed: 13a-15(e)  
−Removed: and 15d-15(e), as adopted pursuant to Section  
−Removed: 302 of the Sarbanes-Oxley Act of 2002.
+Added: Blanchard, pursuant to Rules 13a-15(e) and 15d-15(e), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
+Added: Certification of Michael Levitz, pursuant to Rules 13a-15(e) and 15d-15(e), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Section 1350 Certifications
1 unchanged sentence
Blanchard, and Michael Levitz, pursuant to 18 U.S.C.
−Removed: Section  
−Removed: 1350, as adopted pursuant to Section  
−Removed: 906 of the Sarbanes-Oxley Act of 2002.
−Removed: The following materials from Anika Therapeutics, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 as filed with the SEC on August 4, 2022, formatted in Inline XBRL (eXtensible Business Reporting Language), as follows:
−Removed: Consolidated Balance Sheets as of June 30, 2022 (unaudited) and December 31, 2021 (unaudited)
−Removed: Consolidated Statements of Operations and Comprehensive Income for the Three and Six Months Ended June 30, 2022 and June 30, 2021 (unaudited)
−Removed: Consolidated Statements of Stockholders’ Equity for the Six Months Ended June 30, 2022 and June 30, 20201(unaudited)
−Removed: Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2022 and June 30, 2021 (unaudited)
+Added: Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
+Added: The following materials from Anika Therapeutics, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 as filed with the SEC on November 9, 2022, formatted in Inline XBRL (eXtensible Business Reporting Language), as follows:
+Added: Consolidated Balance Sheets as of September 30, 2022 (unaudited) and December 31, 2021 (unaudited)
+Added: Consolidated Statements of Operations and Comprehensive Income for the Three and Nine Months Ended September 30, 2022 and September 30, 2021 (unaudited)
+Added: Consolidated Statements of Stockholders’ Equity for the Nine Months Ended September 30, 2022 and September 30, 20201(unaudited)
+Added: Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2022 and September 30, 2021 (unaudited)
Notes to Consolidated Financial Statements (unaudited)
5 unchanged sentences
ANIKA THERAPEUTICS, INC.
−Removed: August 4, 2022
+Added: November 9, 2022
/s/ MICHAEL LEVITZ
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.